![]() |
Volumn 74, Issue 1-3, 2001, Pages 341-347
|
Molecular vehicle for target-mediated delivery of therapeutics and diagnostics
|
Author keywords
Angiogenesis; Drug delivery; Endothelial cells; Gene therapy; VEGF
|
Indexed keywords
DRUG VEHICLE;
HYBRID PROTEIN;
PEPTIDE FRAGMENT;
POLYETHYLENEIMINE;
PROTEIN S;
RECEPTOR SUBTYPE;
RECOMBINANT DNA;
RIBONUCLEASE A;
VASCULOTROPIN;
VASCULOTROPIN RECEPTOR;
CELL LINE;
CHEMICAL MODIFICATION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIAGNOSTIC PROCEDURE;
DRUG CONJUGATION;
DRUG DELIVERY SYSTEM;
GENE TARGETING;
GENE THERAPY;
HUMAN;
HUMAN CELL;
MOLECULE;
PRIORITY JOURNAL;
PROTEIN BINDING;
PROTEIN EXPRESSION;
PROTEIN STRUCTURE;
RECOGNITION;
RECOMBINANT DNA TECHNOLOGY;
ANIMALS;
DRUG DELIVERY SYSTEMS;
ENDOTHELIAL GROWTH FACTORS;
GENE THERAPY;
HUMANS;
LUCIFERASES;
LYMPHOKINES;
NEOPLASMS;
POLYETHYLENEIMINE;
RECEPTOR PROTEIN-TYROSINE KINASES;
RECEPTORS, GROWTH FACTOR;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
RECOMBINANT FUSION PROTEINS;
RIBONUCLEASE, PANCREATIC;
TUMOR CELLS, CULTURED;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 0035816152
PISSN: 01683659
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-3659(01)00345-5 Document Type: Article |
Times cited : (26)
|
References (7)
|